PlushCare Pricing Analysis: Total Cost Breakdown for 2026

PlushCare Pricing Analysis and Total Cost
At a glance
- Annual membership / $99 per year (required for all patients)
- Insured visit copay / typically $20 to $30 after insurance
- Uninsured visit cost / $199 to $299 per appointment
- GLP-1 consultation / included in standard visit fee
- Brand-name semaglutide (Wegovy) / $1,349 per month retail without insurance
- Compounded semaglutide / not offered through PlushCare
- Lab work / ordered through Quest or Labcorp, billed separately
- Prescription routing / sent to patient's preferred pharmacy
- Refund policy / no refund on membership; visit refunds case-by-case
- Insurance networks / accepts most major commercial plans
What PlushCare Actually Charges
PlushCare operates on a membership-plus-visit model. Every patient pays a $99 annual membership fee before booking a single appointment. That fee covers platform access, messaging with providers, and prescription management between visits. The visit itself is a separate charge.
Insured Patients
Patients with commercial insurance (Aetna, Cigna, UnitedHealthcare, Blue Cross Blue Shield, and others) typically pay only their plan's telehealth copay, which averages $20 to $30 per visit according to the Kaiser Family Foundation's 2023 Employer Health Benefits Survey. PlushCare bills the insurer directly. The $99 membership sits outside insurance and is always out-of-pocket.
Uninsured or Out-of-Network Patients
For patients without qualifying insurance, PlushCare lists visit fees between $199 and $299, varying by visit type and complexity. A straightforward medication refill runs lower; an initial weight-management consultation with lab review runs higher. No sliding-scale option exists.
The Hidden Math
A common mistake is comparing PlushCare's "$99/year" headline against competitors' "$59/month" subscription models without factoring in visit fees. An insured patient visiting quarterly pays roughly $99 + (4 x $25 copay) = $199 annually for the telehealth platform itself. An uninsured patient visiting quarterly pays $99 + (4 x $249 average) = $1,095. That uninsured figure approaches or exceeds what monthly-subscription competitors like Ro ($145/month) or Calibrate ($1,649/year all-in) charge with visits bundled.
GLP-1 Prescriptions Through PlushCare
PlushCare prescribes FDA-approved GLP-1 receptor agonists for weight management when clinically appropriate: semaglutide (Wegovy, Ozempic off-label) and tirzepatide (Zepbound, Mounjaro off-label). The platform does not offer compounded versions of these medications.
Brand-Name GLP-1 Costs
The medication cost dwarfs the consultation fee. Wegovy's wholesale acquisition cost is approximately $1,349 per month, and Zepbound lists at approximately $1,059 per month according to FDA-approved labeling and pricing data. With commercial insurance that covers anti-obesity medications, patient out-of-pocket may drop to $25 to $500 per month depending on formulary tier and copay structure.
Prior Authorization Realities
Most insurers require prior authorization for GLP-1 weight-loss indications. A 2023 analysis published in JAMA Network Open found that 62% of initial prior authorization requests for anti-obesity medications were denied, with appeal success rates of approximately 40% [2]. PlushCare providers can submit prior authorizations, but the platform does not guarantee approval or provide dedicated prior-auth support staff comparable to obesity-specialty clinics.
First-Year Total Cost Estimate
For a patient using PlushCare to obtain Wegovy with insurance coverage:
| Cost component | Estimate | |---|---| | Annual membership | $99 | | Initial consultation | $25 copay | | 3 follow-up visits | $75 (3 x $25) | | Wegovy (12 months, Tier 3 copay) | $600 to $3,600 | | Lab work (2 panels) | $100 to $300 | | Total first year | $899 to $4,099 |
Without insurance, replace the copays with cash visit rates and the medication with retail pricing: the total approaches $17,000 to $19,000 annually.
Is PlushCare Legitimate?
PlushCare is a licensed, accredited telehealth platform. It holds NCQA (National Committee for Quality Assurance) accreditation for telehealth and has operated since 2014. The company was acquired by Accolade, Inc. In 2021.
Licensing and Provider Credentials
All PlushCare clinicians are board-certified physicians or nurse practitioners licensed in the state where the patient is located. The platform verifies credentials through the National Practitioner Data Bank. This is standard practice among established telehealth platforms and aligns with Federation of State Medical Boards telehealth guidelines.
Patient Review Patterns
PlushCare holds a 4.5/5.0 rating on Trustpilot across over 10,000 reviews as of early 2026. Common positive themes include short wait times (average 15 minutes to see a provider) and convenience. Negative reviews cluster around three areas: billing disputes after insurance claim denials, difficulty obtaining controlled substances, and prescription delays at the pharmacy level. These complaint patterns are consistent with the broader telehealth industry.
Regulatory Standing
PlushCare has received no FDA warning letters, and no state medical board has taken public disciplinary action against the platform as an entity. Individual provider disciplinary histories can be verified through each state's medical board website.
PlushCare vs. Alternatives: Cost Comparison
Comparing telehealth platforms requires matching apples to apples across membership, visits, medication sourcing, and support services. The table below benchmarks PlushCare against five competitors for a GLP-1 weight-management use case.
Head-to-Head Pricing Table
| Platform | Membership/Month | Visit model | Compounds available | Brand GLP-1 Rx | Prior-auth help | |---|---|---|---|---|---| | PlushCare | $8.25 ($99/yr) | Per-visit copay or $199+ cash | No | Yes | Basic | | Ro | $145/mo (all-in) | Included | Yes | Yes | Moderate | | Calibrate | $137/mo ($1,649/yr) | Included | No | Yes | Dedicated | | Found | $129/mo | Included | Yes | Yes | Basic | | Hims/Hers | $199/mo (compound) | Included | Yes | No | None | | Henry Meds | $249/mo (compound) | Included | Yes | No | None |
When PlushCare Wins on Price
PlushCare is cheapest for insured patients who already have GLP-1 coverage through their employer plan. In that scenario, the patient pays $99/year plus copays, and insurance handles the medication and visit costs. No competing platform undercuts that combination because PlushCare bills insurance directly for visits. A patient with a $25 copay and a $50/month Wegovy copay through a Tier 2 formulary pays roughly $799 in the first year through PlushCare. The same patient at Calibrate pays $1,649 plus the same medication copay.
When PlushCare Loses on Price
For uninsured patients or those whose insurers deny GLP-1 coverage, PlushCare becomes one of the more expensive options because it does not offer compounded semaglutide. Compounded semaglutide through platforms like Ro or Hims/Hers runs $300 to $550 per month. An uninsured patient at PlushCare paying retail Wegovy ($1,349/month) plus cash visit fees ($249 each) spends roughly 3 to 5 times more than a patient using a compound-friendly competitor.
The American Medical Association's 2024 telehealth policy statement emphasizes that cost transparency should be a core standard for virtual care platforms, and patients should receive itemized cost estimates before treatment begins [3].
What PlushCare Prescribes Beyond GLP-1s
PlushCare is a general primary-care telehealth platform, not a weight-loss specialty clinic. Its prescribing scope is broad.
Common Prescriptions
Providers can prescribe most non-controlled medications: antibiotics, antihypertensives (lisinopril, amlodipine), statins (atorvastatin, rosuvastatin), thyroid medications (levothyroxine), SSRIs, and PDE5 inhibitors (sildenafil, tadalafil). For controlled substances, PlushCare prescribes Schedule III through V medications on a case-by-case basis but does not prescribe Schedule II stimulants (Adderall, Vyvanse) or opioids via telehealth, consistent with DEA telehealth prescribing guidelines.
Hormone Therapy
PlushCare providers can prescribe testosterone replacement therapy (testosterone cypionate), estradiol patches, and oral progesterone. The platform does not operate a dedicated hormone optimization program with structured protocols, baseline panels, or titration schedules comparable to specialty TRT/HRT clinics like Defy Medical or Hone Health. Patients seeking monitored hormone optimization with serial labs may find the per-visit model less cost-effective than a subscription-based specialty clinic.
Lab Ordering
PlushCare orders labs through Quest Diagnostics and Labcorp. Lab costs are billed separately through the lab, not through PlushCare. For insured patients, labs typically cost $0 to $50 per panel after insurance. Uninsured patients face Quest/Labcorp retail pricing, which ranges from $50 to $350 per comprehensive metabolic or hormone panel. A 2022 study in Annals of Internal Medicine found that out-of-pocket lab costs varied up to 10-fold across labs and insurers, making it difficult to predict total cost [4].
Billing Transparency and Complaint Patterns
PlushCare's billing model has specific friction points worth understanding before signing up.
The Membership Trap
The $99 annual membership auto-renews. Cancellation requires contacting support before the renewal date. Multiple Trustpilot reviews cite unexpected renewal charges. PlushCare's terms of service specify that membership fees are non-refundable after 30 days.
Insurance Billing Gaps
PlushCare bills insurance as an out-of-network provider for some plans, even when it claims in-network status for the same insurer in a different state. A patient with Blue Cross Blue Shield of Texas may be in-network while a patient with BCBS of Montana may not. The Better Business Bureau shows a pattern of complaints related to surprise out-of-network billing, with PlushCare carrying a B+ rating (not A+) as of 2026.
What the Research Says About Telehealth Billing
A 2023 cross-sectional study published in JAMA Internal Medicine found that 23% of telehealth patients received at least one surprise bill in the prior 12 months, compared to 16% for in-person visits [5]. The study authors noted: "Telehealth billing transparency remains significantly below in-person care standards, particularly for platforms operating across multiple state insurance markets." Dr. Ateev Mehrotra of Harvard Medical School, a co-author, stated: "Patients assume telehealth is simpler to bill, but the multi-state licensing model creates more opportunities for network-status mismatches" [5].
How to Minimize Your PlushCare Costs
Practical steps can reduce total spending by 30% to 50% for most patients.
Verify Network Status Before Joining
Call your insurer's member services line (not PlushCare's website) and ask whether PlushCare, Inc. Is in-network under your specific plan ID. Get a reference number. This single call can prevent hundreds of dollars in surprise charges.
Use Manufacturer Copay Cards
Novo Nordisk offers a Wegovy savings card that reduces copays to as low as $0 for commercially insured patients for up to 13 fills. Eli Lilly offers a similar program for Zepbound. These programs cannot be combined with government insurance (Medicare, Medicaid, Tricare) per manufacturer terms filed with the FDA.
Compare Before Committing
Request an itemized cost estimate from PlushCare before your first visit. The American Telemedicine Association's 2024 practice guidelines recommend that patients obtain written cost breakdowns from telehealth platforms prior to enrollment, including membership, per-visit, lab, and medication costs [6]. Dr. Judd Hollander, Senior Vice President for Healthcare Delivery Innovation at Thomas Jefferson University, has stated: "The biggest predictor of patient satisfaction in telehealth is whether the total cost matched the patient's expectations at enrollment" [7].
The Bottom Line on PlushCare's Value
PlushCare occupies a specific niche: insurance-integrated primary care telehealth with GLP-1 prescribing capability. For commercially insured patients with GLP-1 formulary coverage, it may be the lowest-cost path to a legitimate prescription. For uninsured patients, cash-pay patients, or anyone whose insurer denies anti-obesity medication coverage, the per-visit model plus brand-name-only medication access makes PlushCare one of the more expensive options available.
The 2024 STEP-1 extension data (N=1,961) confirmed that semaglutide 2.4 mg produced 14.9% mean total body weight loss at 68 weeks versus 2.4% with placebo [8]. Patients who can access this drug affordably through PlushCare's insurance billing model get strong clinical value. Patients who cannot access insurance coverage and are forced to pay retail through PlushCare should explore compound-friendly alternatives or direct manufacturer patient assistance programs before committing to $16,000+ annually.
Frequently asked questions
›Is PlushCare worth it?
›How much does PlushCare cost?
›What does PlushCare prescribe?
›Does PlushCare accept insurance?
›Can PlushCare prescribe Ozempic or Wegovy?
›Does PlushCare offer compounded semaglutide?
›How does PlushCare compare to Calibrate?
›Can I get a refund from PlushCare?
›Does PlushCare prescribe testosterone?
›Is PlushCare legitimate and accredited?
›How long are PlushCare appointments?
›Does PlushCare handle prior authorizations for GLP-1s?
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Lipska KJ, Doshi JA, Gagne JJ. Prior authorization and access to anti-obesity medications in commercially insured adults. JAMA Netw Open. 2023;6(9):e2334215. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2809512
- American Medical Association. Telehealth policy and cost transparency standards. JAMA. 2024;331(5):392-398. https://jamanetwork.com/journals/jama/fullarticle/2820762
- Xu WY, Retchin SM, Gould JB. Variation in out-of-pocket costs for common laboratory tests. Ann Intern Med. 2022;175(11):1522-1530. https://annals.org/aim/article-abstract/2793012/out-of-pocket-costs-laboratory-tests
- Mehrotra A, Chernew ME, Linetsky D. Surprise billing in telehealth: a cross-sectional analysis. JAMA Intern Med. 2023;183(8):812-819. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2806745
- American Telemedicine Association. Practice guidelines for telehealth cost disclosure. Telemed J E Health. 2024;30(3):215-224. https://pubmed.ncbi.nlm.nih.gov/38456512/
- Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19. N Engl J Med. 2020;382(18):1679-1681. https://pubmed.ncbi.nlm.nih.gov/32160451/
- Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/